Cur9.0

Curcumin

Curcumin (Turmeric Extract)

A powerful anti-inflammatory compound from turmeric that reduces inflammation, supports mood, and aids recovery.

immunitymentalinflammationmoodantioxidantrecovery
Last reviewed: January 1, 2025
9.0/10
40+ studies
Evidence
high
Safety
500-1000mg daily (enhanced form)
Dose
4-8 weeks
Time to Effect
Enhanced absorption form: Longvida, Meriva, or BCM-95
Best Form

Curcumin is the primary active compound in turmeric, with potent anti-inflammatory and antioxidant effects. Standard curcumin has very poor absorption (<1%), so enhanced absorption forms are essential. Recent meta-analyses show benefits for inflammation, mood, and recovery.

Mechanisms of Action

🔥
NF-κB Inhibition

Blocks the master inflammatory pathway

💊
COX-2 Inhibition

Reduces inflammatory prostaglandins

🛡️
Antioxidant Activity

Neutralizes free radicals and oxidative stress

Recommended Dose

500-1000mg daily (enhanced form)

250mg2000mg

Optimal Timing

  • With fatty meal

Take with food

Best Form

Enhanced absorption form: Longvida, Meriva, or BCM-95

Alternatives: CurcuWIN, Theracurmin, Standard curcumin + piperine

CRITICAL: Standard curcumin has <1% absorption. Must use enhanced form. Longvida shown to cross blood-brain barrier. Meriva well-studied for joints.

Duration

Minimum: 4 weeks

Optimal: 8 weeks

Cycling: Not required

Note: Must take with fat for absorption. Piperine (black pepper) increases absorption 2000%. Enhanced forms don't require piperine.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🔥
Lower Inflammation

Reduced CRP and inflammatory markers

4-8 weeks
75% of users notice thispositive
🦵
Joint Comfort

Reduced joint pain and stiffness

4-8 weeks
70% of users notice thispositive
😊
Better Mood

Reduction in depressive symptoms

4-8 weeks
60% of users notice thispositive
🟡
Yellow Staining

Can stain teeth, skin, and surfaces

Immediate
50% of users notice thistrade-off
High SafetyMax safe dose: Up to 8g/day used in short-term studies; typical doses 500-2000mg
🔴
Pregnant/nursing

Avoid — High concentrations may stimulate uterine contractions and affect blood clotting

🟡
Surgery patients

Stop 2 weeks before surgery due to blood thinning effects

Who Should NOT Take This

  • Gallbladder disease
  • Bleeding disorders
  • Scheduled surgery (stop 2 weeks before)

Drug Interactions

Blood thinnersmoderate

May increase bleeding risk

Diabetes medicationsmild

May enhance blood sugar lowering

May reduce iron absorption

Possible Side Effects

GI upsetuncommon

Tip: Take with food; reduce dose

Headacherare

Tip: Reduce dose

Warnings

  • MUST use enhanced absorption form
  • Standard curcumin is poorly absorbed
  • May stain surfaces yellow

Top studies from 40+ peer-reviewed papers

meta-analysisn=4599
DOI

Zhang Y et al. • Nutrients (2025)

“However, further large-scale, well-designed randomized controlled trials (RCTs) are needed to confirm these findings, particularly those that include more standardized dosages and formulations, as well as to evaluate their long-term efficacy.”
Key Findings:
  • Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
  • Conclusions: Nutritional supplements, particularly Boswellia, appear to be effective and well-tolerated for improving KOA symptoms and function.
  • These results suggest that certain supplements may be useful as part of non-pharmacological KOA management.
  • However, further large-scale, well-designed randomized controlled trials (RCTs) are needed to confirm these findings, particularly those that include more standardized dosages and formulations, as well as to evaluate their long-term efficacy.
meta-analysisn=7216
DOI

Jafari A et al. • Phytotherapy research : PTR (2024)

“Trial registration: PROSPERO: CRD42021251969.© 2024 John Wiley & Sons Ltd.”
Key Findings:
  • We meta-analyzed the effect sizes across eligible studies using the random-effects model.
  • Overall, 23 out of 42 (55%) outcomes reported statistically significant effect sizes.
  • In conclusion, curcumin supplementation can modify FBS and some glycemic indices, lipid parameters, as well as inflammatory and oxidative parameters.
  • This updated summary of the accumulated evidence may help inform clinicians and future guidelines regarding medical and scientific interest in curcumin.
meta-analysisn=17437
DOI

Cheng YC et al. • Psychological medicine (2025)

“This extensive systematic review and NMA of nutraceuticals for treating depressive disorders indicated a number of nutraceuticals that could offer benefits, either as adjuncts or monotherapies.”
Key Findings:
  • Adjunctive nutraceuticals consistently showed better efficacy than antidepressants (ADT) alone in outcomes including SMD, remission, and response.
  • This extensive systematic review and NMA of nutraceuticals for treating depressive disorders indicated a number of nutraceuticals that could offer benefits, either as adjuncts or monotherapies.
  • Further research warranted to confirm findings
meta-analysisn=531
DOI

Yu L et al. • The journal of prevention of Alzheimer's disease (2025)

“Preclinical in vivo evidence suggests curcumin enhances cognitive function in AD models.”
Key Findings:
  • In preclinical in vivo murine studies (n = 25; total animals = 572), curcumin consistently improved both acquisition memory (SMD = -1.78, 95 % CI: -2.12 to -1.43) and retention memory (SMD = 2.36, 95 % CI: 1.72 to 3.00) in rodent models of AD.
  • Overall, curcumin showed no significant effect on global cognitive outcomes compared to placebo (SMD = 0.14, 95 % CI: -0.78 to 1.07).
  • Subgroup analyses revealed significant improvements in working memory (SMD = 1.01, 95 % CI: 0.15 to 1.87) and processing speed (SMD = 0.37, 95 % CI: 0.07 to 0.67).
meta-analysis
DOI

Guo Y et al. • Phytotherapy research : PTR (2025)

“Phytotherapy Research published by John Wiley & Sons Ltd.”
Key Findings:
  • Meta-analysis results showed that curcumin significantly reduced tumor volume of mice (p < 0.001) in the NSCLC group compared to the control group.
  • In this study, the effectiveness of curcumin has been demonstrated in in vivo models of NSCLC by meta-analysis.
  • AURKB has been identified as a high-risk target for NSCLC by network pharmacological analysis and MR for the first time.
  • Our study provides a scientific basis for clinical applications of curcumin in NSCLC.© 2025 The Author(s).
40
Total Studies
9.1/10
Avg Quality
11-17,437
Sample Size Range
2016-2025
Research Span

Study Type Distribution

Meta-Analysis
25
RCT
14
Systematic Review
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.